NKI Early cancer detection conference 2027
Early detection of cancer holds enormous promise, but when does it truly translate into meaningful benefit for patients and populations? This conference brings together leading experts to critically examine the evidence behind early detection, moving beyond implementation toward demonstrated impact. We will explore what works, what doesn’t, and where the real value lies.
At the same time, advancing early detection requires continuous innovation rooted in fundamental research. By bridging discovery, evidence, and real-world application, we aim to connect insights from the lab with outcomes in practice. From biomarker development to population-level screening strategies, this meeting highlights the pathways that turn scientific progress into tangible health gains.
Together, we will define the next steps: how to strengthen the evidence base, improve methodologies, and ensure that early detection delivers on its promise, now and in the future.